Get started
Author

Sung-Chao Chu

ORCID: 0000-0002-2737-0787
Observed ORCID: 0000-0002-2737-0787
OpenAlex ID: A5033428085
Dasatinib in Chronic Myelogenous Leukemia
2006 · Sung-Chao Chu, Jih-Luh Tang, et al. · New England Journal of Medicine · 18
Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study
2024 · Kun-Han Lue, Yu-Hung Chen, et al. · Annals of Nuclear Medicine · 7
The prognostic value of 18F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy
2025 · Kun-Han Lue, Yung-Hsuan Wang, et al. · Annals of Nuclear Medicine · 3
Clinical Value of 18F-FDG PET in Paraneoplastic and Pembrolizumab-Associated Myositis
2026 · Chang-Shen Tseng, Yu-Hung Chen, et al. · Diagnostics · 1
PDF
Supplemental Material for: Complete Response to Low-Dose Fam-Trastuzumab Deruxtecan in Recurrent Endometrial Cancer with Liver and Peritoneal Metastases: A Case Report
2026 · figshare admin karger, Fang-Yu Wang, et al. · Figshare
Additional file 1 of AQP0 is a novel surface marker for deciphering abnormal erythropoiesis
2021 · Tso-Fu Wang, Lin, Guan-Ling, et al. · Figshare
Lower lymphocyte percentage and higher platelet count as poor prognostic factors for patients with epidermal growth factor receptor–mutated lung adenocarcinoma receiving tyrosine kinase inhibitors as first-line treatment
2019 · Yi-Feng Wu, Chih-Bin Lin, et al. · Research Square
PDF
Works count: 7
Citation count: 29
H-index: 3
I10-index: 1
Year
Topic
Type